Junior Victoria Wible Tackles Energy Transitions in Sociology Co-op | CoAS drexel.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from drexel.edu Daily Mail and Mail on Sunday newspapers.
ZOOM PROTOCOL
Upon registering for this webinar, you will then receive a confirmation email. If you do not, please check your Spam folder. If you still do not see the email within 24 hours or have other questions please email Mrs. Sarah Wang at wangs@eastwestcenter.org. The confirmation email will provide you with a unique link to join the seminar. Do not share this with anyone else.
As an Attendee in a Zoom Webinar, your microphone will be muted and video turned off from the start of the presentation to cut down on noise interference and to maintain security. Webinar attendees will be welcome to ask questions via the Q&A box throughout the discussion.
Weighing up the Covid risk - is it too early to lift lockdowns in the UK?
Many people are frustrated with the ongoing regulations - but measuring the risk is not purely about numbers of cases and deaths
Daniel Smith
Updated
The video will auto-play soon8Cancel
Play now
Sign up to our newsletter for daily updates and breaking newsInvalid EmailSomething went wrong, please try again later.
Sign up here!
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
Oligonucleotide Therapeutics and Delivery 2021
SMi reports: Speakers confirmed at Oligonucleotide Therapeutics and Delivery Conference, which will convene in London on 22nd and 23rd September. LONDON, LONDON BRIDGE , UNITED KINGDOM, May 11, 2021 /EINPresswire.com/ Oligonucleotidetherapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA, RNAi, saRNA and siRNA. The Oligonucleotide Therapeutics and Delivery conference is here to keep you updated with discussions that will be centered around improving targeted therapy uniting the field’s biggest players to share their opinions. This year’s agenda will encompass key drivers and hot topics of the industry including recent advances in oligonucleotide therapeutics, optimising oligonucleotide development strategies, clinical advances of RNAi therapy and emerging delivery solutions.